Published financial brief
0241B
GOHEALTH INC
- As of
- 2024-12-31
- Source
- Supabase fundamentals
- Calculator
- financial-roic-1.0.0
- Published
- 7/26/2026
2 data notes
- Input provenance requires review.
- One or more values are unavailable.
Exact-period record
Fundamentals
5 reported periods
| Metric | FY 20202020-12-31 | FY 20212021-12-31 | FY 20222022-12-31 | FY 20232023-12-31 | FY 20242024-12-31 |
|---|---|---|---|---|---|
| Financial statements | |||||
| RevenueUSD millions | 877.4 | 1,062.4 | 631.7 | 734.7 | 798.9 |
| Cost of goods soldUSD millions | 194.7 | 225.9 | 174.7 | 147.3 | 118.8 |
| Selling, general and administrative expenseUSD millions | 419.6 | 831.9 | 649.5 | 553.3 | 580.4 |
| Depreciation and amortizationUSD millions | 98.6 | 107.5 | 107 | 105.8 | 105.9 |
| Net incomeUSD millions | -44.3 | -189.4 | -148.7 | -63.3 | -2.9 |
| Operating profit (EBIT)USD millions | 164.5 | -102.9 | -299.5 | -71.7 | -6.1 |
| Income taxesUSD millions | 0 | -0 | 0.8 | 0.2 | 2.3 |
| Short-term debtUSD millions | 4.5 | 11.5 | 14.2 | 80.8 | 45.2 |
| Long-term debtUSD millions | 396.5 | 684.9 | 543.2 | 462.3 | 482.8 |
| Cash and equivalentsUSD millions | 144.2 | 84.4 | 16.5 | 90.8 | 40.9 |
| ReceivablesUSD millions | 218.4 | 306 | 380.1 | 372.5 | 345.8 |
| InventoryUSD millions | 0 | 0 | 0 | 0 | 0 |
| PayablesUSD millions | 8.7 | 39.8 | 15.1 | 17.7 | 14.6 |
| Net property, plant and equipmentUSD millions | 17.4 | 47.7 | 46.8 | 48.8 | 48.6 |
| Capital expenditureUSD millions | 14.5 | 19.8 | 13.5 | 13.7 | 13.7 |
| Operating cash flowUSD millions | -114.2 | -299 | 60.9 | 109.1 | -21.6 |
| Prepaid expensesUSD millions | —missing | —missing | —missing | —missing | —missing |
| AccrualsUSD millions | 105.4 | 157 | 175.4 | 190.2 | 190.3 |
| EBITDAUSD millions | 263 | 4.6 | -192.5 | 34.1 | 99.7 |
| Working capitalUSD millions | 264.5 | 211.9 | 149.1 | 106.4 | 62.4 |
| Working capital requirementUSD millions | 209.7 | 266.2 | 365 | 354.8 | 331.2 |
| Total debtUSD millions | 401 | 696.4 | 557.4 | 543.1 | 528 |
| Free cash flowUSD millions | -128.7 | -318.8 | 47.4 | 95.4 | -35.3 |
| Unlevered free cash flowUSD millions | 150.8 | -71.7 | -304.8 | 30.5 | 109.6 |
| Returns and ratios | |||||
| ROICratio | 9.7% | -11.3% | -32.8% | -9% | -0.9% |
| Pre-tax ROICratio | 9.7% | -11.3% | -32.8% | -9% | -0.9% |
| Effective tax rateratio | 0% | 0% | 0% | 0% | 0% |
| Revenue growthratio | 62.6% | 21.1% | -40.5% | 16.3% | 8.7% |
| EBIT / Revenueratio | 18.7% | -9.7% | -47.4% | -9.8% | -0.8% |
| Revenue / Invested capitalmultiple | 0.52× | 1.17× | 0.69× | 0.92× | 1.17× |
| Cogs Over Revenuesratio | 22.2% | 21.3% | 27.7% | 20% | 14.9% |
| Sga Over Revenuesratio | 47.8% | 78.3% | 102.8% | 75.3% | 72.6% |
| Da Over Revenuesratio | 11.2% | 10.1% | 16.9% | 14.4% | 13.3% |
| Nfa Over Revenuesratio | 2% | 4.5% | 7.4% | 6.6% | 6.1% |
| Wcr Over Revenuesratio | 23.9% | 25.1% | 57.8% | 48.3% | 41.5% |
| Debt Over Ebitdamultiple | 1.52× | 150.96× | —missing | 15.94× | 5.29× |
| St Debt Over Cashmultiple | 0.03× | 0.14× | 0.87× | 0.89× | 1.1× |
| Interest Over Ebitdamultiple | 0.13× | 7.26× | —missing | 2.04× | 0.73× |
| Interest Over Nocf Nicfmultiple | -0.26× | -0.11× | 1.2× | 0.73× | -2.06× |
| Nsf Over Wcrmultiple | -0.67× | -0.27× | -0.01× | -0.03× | 0.01× |
Ask this snapshot
Research assistant
0241B · annualSnapshot 7ef249b8
Answers use only this published snapshot. The assistant will say when the data is insufficient and does not create forecasts, scenarios, or investment advice.
0 / 2,000